Praxis Precision Medicines, Inc. (PRAX) Financial Statements
Praxis Precision Medicines, Inc. (PRAX) reported trailing twelve-month revenue of $0 (up 41442.6% year on year) and net income of -$339.1M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$306.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PRAXPraxis Precision Medicines, Inc.Follow PRAX — free
—
Price chart with a free account
- Market cap
- 7.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.01 | 0.00 | — | |
| Research & development | 0.09 | 0.15 | 0.27 | 0.29 | |
| Operating income | -0.13 | -0.20 | -0.33 | -0.38 | |
| Pre-tax income | -0.12 | -0.18 | -0.30 | -0.34 | |
| Income tax | — | — | 0.00 | — | |
| Net income | -0.12 | -0.18 | -0.30 | -0.34 | |
| Diluted EPS ($) | -18.69 | -10.21 | -13.48 | -11.63 | |
| Diluted shares (bn) | 0.007 | 0.018 | 0.023 | — |
USD billions · SEC XBRL
Praxis Precision Medicines, Inc. — questions
- What is Praxis Precision Medicines, Inc.'s revenue?
- $0 over the twelve months to 2026-06-30, up 41442.6% year on year, from its 10-Q and 10-K filings.
- What is Praxis Precision Medicines, Inc.'s net income?
- -$339.1M over the twelve months to 2026-06-30.
- What is Praxis Precision Medicines, Inc.'s free cash flow?
- -$306.2M over the twelve months to 2026-06-30.
- What are Praxis Precision Medicines, Inc.'s diluted earnings per share?
- $-11.63 over the twelve months to 2026-06-30.
Every figure on this page comes from Praxis Precision Medicines, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.